Cyclo Therapeutics Inc Ordinary Shares - Class A CYTH 深 沪
已收盘 03-26 16:00:00 美东时间
0.7206
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 0.7206
- 总市值 2.36万
- 52周最高 1.6199
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 0.55
- 委 比 0.00%
- 总股本 3.27万
- 历史最高 17.75
- 量 比 0
- 振 幅 0.00%
- 历史最低 0.55
- 每 手 1
- 风险率 0.00%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Why Is Rafael Stock Falling Wednesday?
Rafael Holdings Inc. (NYSE:RFL) stock is trading lower on Wednesday after the company shared topline efficacy and safety findings from its subsidiary Cyclo Therapeutics LLC‘s pivotal Phase 3 TransportNPC study of Trappsol Cyclo in Niemann-Pick Disease Type C (NPC). The micro-cap biotech company had ...
10-01 01:39
Rafael Holdings Announced Topline Efficacy And Safety Data From Its Cyclo Therapeutics Subsidiary’s Phase 3 TransportNPC Study Evaluating Trappsol Cyclo In 94 Patients Diagnosed With Niemann-Pick Disease Type C; Trappsol Cyclo Did Not Achieve Statistical Significance
Trappsol® Cyclo™ was well tolerated and demonstrated a directionally favorable treatment effect on the primary endpoint, although the result did not achieve statistical significance. Notably, a prespecified analysis in patients receiving background miglustat and/or leucine therapy demonstrated a sta...
09-30 19:07
Rafael Holdings' Cyclo Therapeutics Enters Into Exclusive Licensing Agreement With MIT For Small Molecules To Improve Myelination In Apoe4 Positive Alzheimer's Disease
Rafael Holdings, Inc. (NYSE:RFL) today announced that its subsidiary, Cyclo Therapeutics, has entered into an exclusive licensing agreement with Massachusetts Institute of Technology ("MIT") covering U.S. Patent
04-22 19:04
Rafael Holdings shares are trading lower. The company announced its subsidiary Cyclo Therapeutics' 96-week pivotal phase 3 TransportNPC study evaluating intravenous Trappsol Cyclo for the potential treatment of Niemann-Pick Disease Type C1 will continue based on the independent Data Monitoring Committee review of safety and efficacy data at the prespecified 48-week interim analysis.
Rafael Holdings shares are trading lower. The company announced its subsidiary ...
2025-06-18 22:38
Cyclo Therapeutics Merges with Rafael Holdings
An update from Cyclo Therapeutics ( ($CYTH) ) is now available. On March 25, 20...
2025-03-26 19:27
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Tenon Medical (NASDAQ:TNON) stock increased by 367.2% to $4.57 during ...
2025-03-25 20:10
